Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/61568
Title: Nanoparticles in Cancer Treatment: Opportunities and Obstacles
Contributor(s): Awasthi, Rajendra (author); Roseblade, Ariane (author); Hansbro, Philip (author); Rathbone, Michael John (author); Dua, Kamal (author); Bebawy, Mary  (author)orcid 
Publication Date: 2018
Publisher: Bentham Science Publishers Ltd
Place of Publication: United Arab Emirates
DOI: 10.2174/1389450119666180326122831
Handle Link: https://hdl.handle.net/1959.11/61568
ISSN: 1873-5592
1389-4501
Source of Publication: Current Drug Targets, 19(14), p. 1696-1709
Abstract: 

In the United States, the estimated number of new cancer cases in 2018 will be approx. 1.7 million. Historically, combination chemotherapy has been the primary choice of treatment. However, chemotherapeutics have pharmaceutical limitations, among which include problems with stability and aqueous solubility. Likewise, dose limiting toxicity is significant with nonspecific toxicity to healthy cells, hair loss, loss of appetite, peripheral neuropathy and diarrhea being typical side effects. The emergence of Multidrug resistance (MDR) also presents s a significant challenge for the successful treatment of cancer whereby cancer cells become cross resistant to many of the chemotherapeutic agents used. Nanotechnology presents a new frontier for cancer treatment. It holds potential in minimizing systemic toxicity through the development of functionalized particles for targeted treatment. They also provide an alternative strategy to circumvent multidrug resistance as they have a capacity to by-pass the drug efflux mechanism associated with this phenotype. Aside from the advantages they offer in treatment, nanoparticles are also emerging to be valuable diagnostic entities. This article highlights the various ways nanotechnology is being used to improve the treatment and management of cancer. We also discuss the opportunities and obstacles in this area and provide an up to date review of progress in the treatment of cancer.

Publication Type: Journal Article
Fields of Research (FoR) 2020: 3208 Medical physiology
Socio-Economic Objective (SEO) 2020: TBD
HERDC Category Description: C1 Refereed Article in a Scholarly Journal
Peer Reviewed: Yes
Appears in Collections:Import

Show full item record

SCOPUSTM   
Citations

150
checked on Jul 13, 2024
Google Media

Google ScholarTM

Check

Altmetric


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.